Global Cardiovascular Pharmaceuticals Market to be Propelled by Growing Investment in Research and Drug Development, and Increasing Prevalence of Heart Failure by CAGR of 5% During 2023- 2033

Kenneth Research published a report titled "Cardiovascular Pharmaceuticals Market: Global Demand Analysis & Opportunity Outlook 2033" which delivers detailed overview of the global cardiovascular pharmaceuticals market in terms of market segmentation by drug class, distribution channel, indication and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
Detailed description: https://www.kennethresearch.com/report-details/cardiovascular-pharmaceuticals-market/10080125
The global cardiovascular pharmaceuticals market is expected to grow at ~5% CAGR over the forecast period, i.e., 2023-2033. The market is segmented by indication into hypertension, arrhythmia, coronary artery disease, and hyperlipidemia. Out of these, the hypertension segment is expected to hold the largest share over the forecast period in the global cardiovascular pharmaceuticals market. This can be attributed to unhealthy lifestyle choices and lack of exercise among the population.
The global cardiovascular pharmaceuticals market is estimated to grow on the back of rising health care costs. Rising demand for more effective cardiovascular drugs followed by growing investment in research and drug development, rising hospitalization and number of admissions in critical care units, increasing prevalence of heart failure, and surge in availability of reimbursement policies is further anticipated to increase the growth of the global cardiovascular pharmaceuticals market.
Geographically, the global cardiovascular pharmaceuticals market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of them, the market in the North America region is projected to hold the largest market share by the end of 2033. This can be attributed to the rise in stress, anxiety, and obesity which is leading to diabetes and heart disease as well as atrial fibrillation, coronary artery disease, and strokes.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Increasing Prevalence of Heart Failure to Boost the Market Growth
Heart failure is a common complication of cardiovascular disorders. Resulting from poor lifestyle decisions, such as eating a lot of salt, smoking, abusing alcohol or drugs, or not taking preventative medications as prescribed
Furthermore, heart failure is becoming more common, with an estimated 27 million people suffering from the disease worldwide.
However, adverse effects of heart medication, expiration of several medications patents, and high cost of cardiovascular drugs are expected to operate as key restraint to the growth of global cardiovascular pharmaceuticals market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global cardiovascular pharmaceuticals market which includes company profiling of Bristol-Myers Squibb Company, Bayer AG, Pfizer Inc., Janssen Pharmaceuticals, Inc., Novartis AG, Merck & Co., AstraZeneca plc, Sanofi S.A., Gilead Sciences, Inc., F. Hoffmann-La Roche, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global cardiovascular pharmaceuticals market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.kennethresearch.com/sample-request-10080125
Kenneth Research is a leading service provider for strategic market research company and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: sales@kennethresearch.com
U.S. Phone: +1 313 462 0609

1412 Broadway, 21st Floor Suite MA111, New York

Kenneth Research provides market research reports to different individuals, industry, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 100,000 research reports provided by more than 25 market research publishers across different industries. Our collection of market research solutions covers both macro level and as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services globally across different industries. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products' demand, growth and opportunities for new and existing players.

This release was published on openPR.